Arbutus Biopharma Corp (ABUS)
2.735
+0.02
(+0.55%)
USD |
NASDAQ |
Apr 26, 10:31
Arbutus Biopharma Market Cap: 492.78M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 490.08M |
| April 24, 2024 | 495.48M |
| April 23, 2024 | 495.48M |
| April 22, 2024 | 475.66M |
| April 19, 2024 | 490.08M |
| April 18, 2024 | 491.88M |
| April 17, 2024 | 500.89M |
| April 16, 2024 | 526.11M |
| April 15, 2024 | 535.12M |
| April 12, 2024 | 524.31M |
| April 11, 2024 | 545.93M |
| April 10, 2024 | 536.92M |
| April 09, 2024 | 541.43M |
| April 08, 2024 | 556.74M |
| April 05, 2024 | 562.15M |
| April 04, 2024 | 540.52M |
| April 03, 2024 | 526.11M |
| April 02, 2024 | 454.04M |
| April 01, 2024 | 461.25M |
| March 28, 2024 | 464.85M |
| March 27, 2024 | 468.45M |
| March 26, 2024 | 448.64M |
| March 25, 2024 | 448.64M |
| March 22, 2024 | 448.73M |
| March 21, 2024 | 457.71M |
| Date | Value |
|---|---|
| March 20, 2024 | 457.71M |
| March 19, 2024 | 448.73M |
| March 18, 2024 | 455.91M |
| March 15, 2024 | 470.27M |
| March 14, 2024 | 468.47M |
| March 13, 2024 | 484.63M |
| March 12, 2024 | 482.83M |
| March 11, 2024 | 488.22M |
| March 08, 2024 | 490.01M |
| March 07, 2024 | 484.63M |
| March 06, 2024 | 491.81M |
| March 05, 2024 | 479.24M |
| March 04, 2024 | 486.42M |
| March 01, 2024 | 500.78M |
| February 29, 2024 | 475.63M |
| February 28, 2024 | 489.22M |
| February 27, 2024 | 496.01M |
| February 26, 2024 | 496.01M |
| February 23, 2024 | 496.01M |
| February 22, 2024 | 494.31M |
| February 21, 2024 | 489.22M |
| February 20, 2024 | 489.22M |
| February 16, 2024 | 492.62M |
| February 15, 2024 | 494.31M |
| February 14, 2024 | 494.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
49.46M
Minimum
Oct 09 2019
628.96M
Maximum
Dec 01 2021
316.41M
Average
340.12M
Median
Aug 31 2021
Market Cap Benchmarks
| Moderna Inc | 41.16B |
| Pacira BioSciences Inc | 1.200B |
| Chimerix Inc | 81.08M |
| Karyopharm Therapeutics Inc | 117.94M |
| Corvus Pharmaceuticals Inc | 75.52M |
Market Cap Related Metrics
| PS Ratio | 25.02 |
| Price to Book Value | 4.648 |
| Price | 2.735 |
| Earnings Yield | -16.09% |